Osteopetrosis. Current clinical considerations.
Osteopetrosis is an inherited skeletal condition characterized by increased bone radiodensity. There are three clinical groups: infantile-malignant autosomal recessive, fatal within the first few years of life (in the absence of effective therapy); intermediate autosomal recessive, appears during the first decade of life but does not follow a malignant course; and autosomal dominant, with full-life expectancy but many orthopaedic problems. The infantile variant shows a myelophthisic anemia, granulocytopenia, and thrombocytopenia, and patients eventually die from infection or bleeding or both. Neurologic sequelae include cranial nerve compression (optic nerve, blindness; auditory nerve, deafness; facial nerve, paresis), hydrocephalus, convulsions, and mental retardation. Radiographs show uniform bone density without corticomedulary demarcation, broadened metaphyses, "bone within a bone" or endobone phenomena (tarsals, carpals, phalanges, vertebra, ilium), and thickened growth plates if there is superimposed rickets. Transverse pathologic fractures occur, often followed by massive periosteal bone formation. Computed tomographic scans, magnetic resonance imaging, and bone scans provide specific information. Iliac crest bone biopsy is valuable to quantitate osteoclast and marrow changes by light and electron microscopy. Medical treatments involve high-dose calcitriol to stimulate osteoclast differentiation and bone marrow transplantation to provide monocytic osteoclast precursors. Orthopaedic problems in the intermediate and autosomal dominant forms include increased fractures, coxa vara, long-bone bowing, hip and knee degenerative arthritis, and mandibular and long-bone osteomyelitis. Cranial nerve compression also occurs. Osteotomy, plating, intramedullary rodding, and joint arthroplasty can be done, but are difficult because of bone hardness.
Shapiro
F
F
Department of Orthopaedic Surgery, Children's Hospital, Boston, MA 02115.
D000750:Anemia, Myelophthisic / Q000150:complications; D001848:Bone Diseases, Developmental / Q000209:etiology; D016026:Bone Marrow Transplantation; D002117:Calcitriol / Q000627:therapeutic use; D002675:Child, Preschool; D003952:Diagnostic Imaging; D004872:Ergocalciferols / Q000097:blood; D005598:Fractures, Spontaneous / Q000209:etiology; D006801:Humans; D007085:Ilium / Q000473:pathology; D007223:Infant; D009422:Nervous System Diseases / Q000209:etiology; D010022:Osteopetrosis / Q000097:blood / Q000150:complications* / Q000175:diagnosis; D010281:Parathyroid Hormone / Q000097:blood
D004872:Ergocalciferols; D010281:Parathyroid Hormone; C003564:1,25-dihydroxyergocalciferol; D002117:Calcitriol